Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting (International Angiology 31, 1 (85-89))

A. L. Abbott, M. A. Adelman, A. V. Alexandrov, H. J.M. Barnett, J. Beard, P. Bell, M. Björck, D. Blacker, C. J. Buckley, R. P. Cambria, A. J. Comerota, E. S. Connolly, A. H. Davies, H. H. Eckstein, R. Faruqi, G. Fraedrich, P. Gloviczki, G. J. Hankey, R. E. Harbaugh, E. HeldenbergS. J. Kittner, T. J. Kleinig, D. P. Mikhailidis, W. S. Moore, R. Naylor, A. Nicolaides, K. I. Paraskevas, D. M. Pelz, J. W. Prichard, G. Purdie, J. B. Ricco, T. Riles, P. Rothwell, P. Sandercock, H. Sillesen, J. D. Spence, F. Spinelli, A. Tan, A. Thapar, F. J. Veith, Wei Zhou

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting (International Angiology 31, 1 (85-89))'. Together they form a unique fingerprint.